Teva Pharmaceutical Industries Ltd. is an international pharmaceutical company headquartered in Israel. It specializes in generic and proprietary pharmaceuticals and active pharmaceutical ingredients. It is one of the 20 largest pharmaceutical companies and is the largest generic drug manufacturer in the world. In 2004, its sales totaled $4.276 billion. After its acquisition of U.S. rival Ivax Corporation in January 2006, the company has about 25,000 workers in 50 countries. Teva says that over 80% of its sales are in North America and Europe.

On June 23, 2006, Teva (through a former Ivax subsidiary) received from the U.S. Food & Drug Administration a 180-day exclusivity period to sell simvastatin (Zocor) in the U.S. as a generic drug in all strengths except 80 mg. Teva presently competes with the maker of brand-name Zocor, Merck & Co.; Ranbaxy Laboratories, which has 180-day exclusivity at 80 mg; and Dr. Reddy's Laboratories, whose authorized generic version (licensed by Merck) is exempt from exclusivity.

References

• Pharmaceutical Executive (PDF)

External links

• Corporate Web site

Pharmaceutical companies | Pharmaceutical companies of the United States | clinical research | Companies of Israel

TEVA | TEVA Pharmaceutical Industries Ltd. | טבע תעשיות פרמצבטיות | Teva